Sales & Marketing News | pharmaphorum

News

Medical groups, federal staffers call for RFK Jr to resign

The call for HHS Secretary Kennedy to resign is fast becoming a clamour, as medical, public health and patient groups, and federal employees chime in.

News

Eisai moves swiftly to expand subcutaneous Leqembi label

Before it has even launched, Eisai has filed to widen subcutaneous Leqembi's label to include starting as well as maintenance dosing in Alzheimer's.

News

A vaccine adcomm expert criticised RFK Jr – now he's out

A prominent critic of RFK Jr's approach to vaccination regulation, Dr Paul Offit, has been removed from an influential FDA advisory committee.

News

Ex-CDC chiefs sound alarm bells over HHS under Kennedy

No fewer than nine former directors of the CDC have said every American should be alarmed at what is happening on HHS Secretary Kennedy's watch.

News

ESC: MSD/Bayer's Verquvo disappoints in heart failure trial

Bayer and MSD's hopes of expanding the use of Verquvo in heart failure have been dashed by a failed phase 3 trial.

News

IPO plan evaporates as private equity firm buys Stada

Stada has confirmed it isn't going ahead with an IPO, as its two private equity owners have just agreed to sell a majority stake to a third.

Medical groups, federal staffers call for RFK Jr to resign

Eisai moves swiftly to expand subcutaneous Leqembi label

A vaccine adcomm expert criticised RFK Jr – now he's out

Ex-CDC chiefs sound alarm bells over HHS under Kennedy

ESC: MSD/Bayer's Verquvo disappoints in heart failure trial

IPO plan evaporates as private equity firm buys Stada

Lilly UK recruits ex-England cricketer as obesity champion

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks